Please login to the form below

Not currently logged in
Email:
Password:

CROS NT names Mark Paul as senior VP of US operations

He joins from Veracity Logic

CROS NTInternational contract research organisation CROS NT has appointed Mark Paul as senior vice president of its US operations.

Paul will be responsible for the company's workings in the US and will represent US interests on the global leadership team.

Commenting on his appointment, Paul said: “I am looking forward to joining CROS NT; the company has a great reputation and a strong team in the US and I am looking forward to working with them and helping the business to grow here. 

“CROS NT has built up a portfolio of business through a combination of strong expertise and excellent customer service; I will continue to grow the US operation with those values in mind”.

Paul brings a wealth of experience to the role and has served in senior management roles at Quintiles, Health Decisions, StatWorks and most recently at Veracity Logic.

Andrew MacGarvey, CEO of CROS NT, added: “I am delighted to welcome Mark to our company. We are growing our customer base in the United States and increasing the size of our group here. 

“Mark has great experience in delivering global projects and in growing and developing operational teams. He will oversee our continued growth in the region and will work closely with our customers to ensure they receive the highest levels of service."


18th June 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....